"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A trial looking at AMG 319 for head and neck cancer
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
Cancer type:
Head and neck cancers
Laryngeal cancer
Mouth (oral) cancer
Status:
Closed
Phase:
Phase 2
This trial is looking at whether a new drug called AMG 319 is a useful treatment for people with certain types of head and neck cancer. It is for people with 
of the
People must be due to have surgery for their head and neck cancer. Cancer Research UK supports this trial.
More about this trial
Doctors are looking at whether a new drug called AMG 319 can help the to attack cancer cells. Doctors have used AMG 319 for a small number of people with leukaemia and now they want to see if it will work in people with head and neck cancers.
AMG 319 is a type of biological therapy called immunotherapy. Immunotherapy uses substances produced by the body’s immune system. These substances help the body to fight infection and disease.
In the trial 1 group of people will have AMG 319.The other group will have a dummy drug (placebo). Everyone will then have surgery.
The aims of the trial are to
- See how the drug affects your immune system and whether this affects your cancer
- Learn more about the side effects of AMG 319
- Understand how the drug works in your body
Who can enter
You may be able to join this trial if all of the following apply
- You have squamous cell cancer of the hypopharynx, mouth, oropharynx, supraglottis or larynx (voicebox)
- You are due to have surgery to remove your cancer
- You have satisfactory blood test results
- You are willing to use reliable contraception during the time of the trial and for up to 6 months afterwards if there is any chance you or your partner could become pregnant
- You are aged 18 or older
If you have a head and neck cancer that has come back (recurred) or you have developed a 2nd tumour, you may still be able to take part in the trial if you had surgery only. You must have had your surgery at least 6 months before starting the trial.
You cannot join this trial if any of these apply. You
- Have already had treatment for your head and neck cancer apart from surgery
- Have any other type of cancer that the trial doctors think could affect you taking part in this trial
- Have had major surgery to your chest or tummy (abdomen) and you have not recovered
- Have any disease, such as an infection, that affects your whole body and which is not controlled by medication
- Have an
autoimmune disease and you may need drugs that suppress the immune system during the time of the trial - Have a problem with the rhythm of your heart , the trial doctors can advise you about this
- Take certain types of steroids or any type of drug that affects the rhythm of your heart, the trial doctors can advise you about this
- Have HIV, hepatitis B or hepatitis C
- Are taking part or plan to take part in another cancer treatment clinical trial
- Have any other condition that the doctors think would affect your taking part in this trial
Trial design
This is a phase 2 trial. The doctors need around 54 people to join.
It is a randomised trial. The people taking part are put into treatment groups by a computer. Neither you nor your doctor will be able to decide which group you are in. And neither of you will know which group you are in. This is called a double blind trial.
- People in one group have AMG 319
- People in the other group have a dummy drug (placebo)
You have a 2 in 3 chance of having AMG 319.
You start taking the AMG 319 or the dummy drug 20 to 29 days before you have your surgery. Both are capsules you take every day. Your doctor will tell how many. You will be given a diary card so you can write down when you take the drug and any problems you may have.
The doctors need to test a sample of your cancer (a ) to look for the and for . You may have had a biopsy when your cancer was diagnosed. If so the doctors may be able to use a piece of this tissue. If not you will need to have a biopsy done. The doctors will tell you what this will involve.
Hospital visits
You will see the doctors and have some tests before you start treatment. The tests may include
During treatment you see the doctor once a week for
- Blood tests
- Urine tests
- Heart trace
You go to hospital on the 1st day of your treatment. Before taking the capsules you have some blood samples taken. The researchers will use these samples to see what happens to AMG 319 in your body. This is called You may also have some urine tested.
During your second visit you have a unless you have had a booster in the last 6 months. You have this vaccination to see if the AMG 319 affects how your immune system responds to the vaccine. You have some blood samples taken before you have the capsules and again 4 hours afterwards.
On your 3rd visit you have more blood samples taken before you have the capsules and again 4 hours afterwards.
You have an MRI scan or CT scan in the 3 days before or on the day of your surgery. This is to see if the size of your cancer has changed since starting treatment.
You finish taking AMG 319 the day before your surgery. You see the doctor 60 days after surgery for
- Blood tests
- Urine test
- Heart trace
If you are starting chemotherapy or radiotherapy after your surgery you will have this visit before you start this treatment.
If you have any side effects from AMG 319 the doctors will continue to see you until they have stopped. Otherwise they will continue to collect information about you when you go to hospital for routine follow up after your surgery or after any additional treatment you have.
Side effects
Because AMG 319 is a new drug there may be some side effects which we don’t know about yet. Part of the trial is looking at the side effects of this drug and you will be given a telephone number so you can call the trial team if you are worried about anything.
The most common side effects of AMG 319 are
- Diarrhoea
- High temperature (fever)
- Feeling sick
- Tummy (abdominal) pain
- Low red and white blood cells causing an increased risk of infection, tiredness and breathlessness
- Skin rash
- Flu like symptoms
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Chief Investigator
Professor Christian Ottensmeier
Supported by
Amgen
Cancer Research UK (Centre for Drug Development)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Other information
This is a Cancer Research UK trial number CRUKD/15/004.
Questions about cancer? Contact our information nurses
Freephone 0808 800 4040
Last review date
CRUK internal database number:
13451
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Wendy took part in a new trial studying the possible side effect of hearing loss
Last reviewed:
About Cancer generously supported by
Dangoor Education since 2010.
Dangoor Education since 2010.